BlackRock Fund Advisors’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$70.8M	Buy	2,221,302 +388,206	+21%	+$12M	0.01%	1447
2016 Q3	$66.4M	Buy	1,833,096 +47,389	+3%	+$1.32M	0.01%	1373
2016 Q2	$40.5M	Buy	1,785,707 +218,112	+14%	+$4.71M	0.01%	1630
2016 Q1	$29.5M	Sell	1,567,595 -16,307	-1%	-$267K	0.01%	1762
2015 Q4	$26M	Sell	1,583,902 -17,538	-1%	-$278K	0.01%	1882
2015 Q3	$17.6M	Sell	1,601,440 -108,249	-6%	-$1.38M	﹤0.01%	2066
2015 Q2	$22.3M	Buy	1,709,689 +209,612	+14%	+$3.25M	0.01%	2046
2015 Q1	$26M	Buy	1,500,077 +299,928	+25%	+$5.5M	0.01%	1932
2014 Q4	$17.9M	Buy	1,200,149 +432,587	+56%	+$7.54M	﹤0.01%	2129
2014 Q3	$17.7M	Sell	767,562 -50,620	-6%	-$1.47M	0.01%	2034
2014 Q2	$26.1M	Buy	+818,182	New	+$24.6M	0.01%	1851